AU2002324881A8 - Diagnostic and prognostic tests - Google Patents
Diagnostic and prognostic testsInfo
- Publication number
- AU2002324881A8 AU2002324881A8 AU2002324881A AU2002324881A AU2002324881A8 AU 2002324881 A8 AU2002324881 A8 AU 2002324881A8 AU 2002324881 A AU2002324881 A AU 2002324881A AU 2002324881 A AU2002324881 A AU 2002324881A AU 2002324881 A8 AU2002324881 A8 AU 2002324881A8
- Authority
- AU
- Australia
- Prior art keywords
- diagnostic
- prognostic tests
- prognostic
- tests
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31738901P | 2001-09-05 | 2001-09-05 | |
US60/317,389 | 2001-09-05 | ||
US10/236,031 | 2002-08-30 | ||
PCT/US2002/028203 WO2003021229A2 (en) | 2001-09-05 | 2002-09-05 | Diagnostic and prognostic tests |
US10/236,031 US7622260B2 (en) | 2001-09-05 | 2002-09-05 | Diagnostic and prognostic tests |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002324881A8 true AU2002324881A8 (en) | 2003-03-18 |
AU2002324881A1 AU2002324881A1 (en) | 2003-03-18 |
Family
ID=26929397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002324881A Abandoned AU2002324881A1 (en) | 2001-09-05 | 2002-09-05 | Diagnostic and prognostic tests |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002324881A1 (en) |
WO (1) | WO2003021229A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7635676B2 (en) * | 2001-02-21 | 2009-12-22 | Alavita Pharmaccuticals, Inc. | Modified annexin proteins and methods for their use in organ transplantation |
US7622260B2 (en) | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
AU2004256182A1 (en) * | 2003-07-02 | 2005-01-20 | Novartis Ag | Genes regulated in ovarian cancer as prognostic and therapeutic targets |
WO2005015236A2 (en) * | 2003-07-18 | 2005-02-17 | Roche Diagnostics Gmbh | A method for predicting the progression of adenocarcinoma |
US8131475B2 (en) | 2003-09-03 | 2012-03-06 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Methods for identifying, diagnosing, and predicting survival of lymphomas |
US20110152115A1 (en) | 2003-09-03 | 2011-06-23 | The United States of America, as represented by the Secretary, Department of Health and | Methods for identifying, diagnosing, and predicting survival of lymphomas |
AU2004271192B2 (en) | 2003-09-03 | 2011-11-17 | Government Of The United States Of America, As Represented By Secretary, Department Of Health And Human Services | Methods for identifying, diagnosing, and predicting survival of lymphomas |
US8321137B2 (en) | 2003-09-29 | 2012-11-27 | Pathwork Diagnostics, Inc. | Knowledge-based storage of diagnostic models |
EP1671121A4 (en) | 2003-09-29 | 2007-12-19 | Pathwork Diagnostics Inc | Systems and methods for detecting biological features |
DE602004020855D1 (en) * | 2003-11-20 | 2009-06-10 | Hoffmann La Roche | Specific markers for metabolic syndromes |
US8450057B2 (en) | 2006-08-14 | 2013-05-28 | The Brigham And Women's Hospital, Inc. | Diagnostic tests using gene expression ratios |
CN104846092A (en) * | 2007-02-21 | 2015-08-19 | 奥斯陆大学医院Hf | New markers for cancer |
CA2726811C (en) | 2008-06-06 | 2019-11-26 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Survival predictor for diffuse large b cell lymphoma |
AU2015251314A1 (en) * | 2014-04-22 | 2016-11-03 | Shanghai Kexin Biotech Co., Ltd. | Method and biomarker for detecting cancer |
CN104368012B (en) * | 2014-08-20 | 2019-03-22 | 中国人民解放军第三〇七医院 | The purposes and its related drugs of people's RPL34 gene |
CN107312846A (en) * | 2017-07-12 | 2017-11-03 | 北京赛尔维康生物医学科技有限公司 | Application of the CAPG and PTGIS genes in scoliosis detection kit is prepared |
CN111912987B (en) * | 2020-08-25 | 2023-07-21 | 北京信诺卫康科技有限公司 | FGF18 and HE4 combined used as early ovarian cancer biomarker and kit |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6040138A (en) * | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5840484A (en) * | 1992-07-17 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
AU3755300A (en) * | 1999-03-15 | 2000-10-04 | Eos Biotechnology, Inc. | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
-
2002
- 2002-09-05 AU AU2002324881A patent/AU2002324881A1/en not_active Abandoned
- 2002-09-05 WO PCT/US2002/028203 patent/WO2003021229A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003021229A3 (en) | 2004-11-25 |
AU2002324881A1 (en) | 2003-03-18 |
WO2003021229A2 (en) | 2003-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002327185A8 (en) | Diagnostic methods and devices | |
GB0104690D0 (en) | Diagnostic test | |
IL160342A0 (en) | Test enabled application execution | |
GB0127322D0 (en) | Test device | |
AU149115S (en) | Analyte test strip | |
EP1413880A4 (en) | Analyzing instrument | |
AUPQ886100A0 (en) | Diagnostic test | |
AU2002324881A8 (en) | Diagnostic and prognostic tests | |
AU2002367856A8 (en) | Diagnostic device | |
GB0128310D0 (en) | Test | |
GB0125179D0 (en) | Diagnostic tests | |
GB0120009D0 (en) | Cause and effect diagnosis | |
EP1412754A4 (en) | Diagnostic methods and agents | |
GB0229444D0 (en) | Diagnostic method and assay kit | |
GB0125180D0 (en) | Diagnostic tests | |
TW549448U (en) | Probe card assembly | |
GB0121996D0 (en) | Diagnostic test | |
GB0025678D0 (en) | Diagnostic test | |
AU2002252875A1 (en) | Cardiovascular disease and thrombotic risk diagnostic tests | |
GB0116311D0 (en) | Non-destructive testing | |
GB0219890D0 (en) | Diagnostic test | |
EP1405069A4 (en) | See through testing device | |
GB0115270D0 (en) | Blood testing unit | |
AU2002251518A1 (en) | Immunochromatographic test piece and diagnosis kit | |
GB9824213D0 (en) | Diagnostic test |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |